Literature DB >> 33590469

Knee osteoarthritis and time-to all-cause mortality in six community-based cohorts: an international meta-analysis of individual participant-level data.

Kirsten M Leyland1,2, Lucy S Gates2,3, Maria T Sanchez-Santos4, Michael C Nevitt5, David Felson6, Graeme Jones7, Joanne M Jordan8, Andrew Judge2,9, Dani Prieto-Alhambra4, Noriko Yoshimura10, Julia L Newton2, Leigh F Callahan8, Cyrus Cooper2,11, Mark E Batt12, Jianhao Lin13, Qiang Liu13, Rebecca J Cleveland8, Gary S Collins4, Nigel K Arden14,15.   

Abstract

BACKGROUND: Osteoarthritis (OA) is a chronic joint disease, with increasing global burden of disability and healthcare utilisation. Recent meta-analyses have shown a range of effects of OA on mortality, reflecting different OA definitions and study methods. We seek to overcome limitations introduced when using aggregate results by gathering individual participant-level data (IPD) from international observational studies and standardising methods to determine the association of knee OA with mortality in the general population.
METHODS: Seven community-based cohorts were identified containing knee OA-related pain, radiographs, and time-to-mortality, six of which were available for analysis. A two-stage IPD meta-analysis framework was applied: (1) Cox proportional hazard models assessed time-to-mortality of participants with radiographic OA (ROA), OA-related pain (POA), and a combination of pain and ROA (PROA) against pain and ROA-free participants; (2) hazard ratios (HR) were then pooled using the Hartung-Knapp modification for random-effects meta-analysis.
FINDINGS: 10,723 participants in six cohorts from four countries were included in the analyses. Multivariable models (adjusting for age, sex, race, BMI, smoking, alcohol consumption, cardiovascular disease, and diabetes) showed a pooled HR, compared to pain and ROA-free participants, of 1.03 (0.83, 1.28) for ROA, 1.35 (1.12, 1.63) for POA, and 1.37 (1.22, 1.54) for PROA. DISCUSSION: Participants with POA or PROA had a 35-37% increased association with reduced time-to-mortality, independent of confounders. ROA showed no association with mortality, suggesting that OA-related knee pain may be driving the association with time-to-mortality. FUNDING: Versus Arthritis Centre for Sport, Exercise and Osteoarthritis and Osteoarthritis Research Society International.

Entities:  

Keywords:  Knee; Meta-analysis; Mortality; Osteoarthritis

Mesh:

Year:  2021        PMID: 33590469      PMCID: PMC7943431          DOI: 10.1007/s40520-020-01762-2

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  48 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

3.  Harmonising measures of knee and hip osteoarthritis in population-based cohort studies: an international study.

Authors:  K M Leyland; L S Gates; M Nevitt; D Felson; S M Bierma-Zeinstra; P G Conaghan; L Engebretsen; M Hochberg; D J Hunter; G Jones; J M Jordan; A Judge; L S Lohmander; E M Roos; M T Sanchez-Santos; N Yoshimura; J B J van Meurs; M E Batt; J Newton; C Cooper; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2018-02-07       Impact factor: 6.576

4.  The impact of painful knee osteoarthritis on mortality: a community-based cohort study with over 24 years of follow-up.

Authors:  R J Cleveland; C Alvarez; T A Schwartz; E Losina; J B Renner; J M Jordan; L F Callahan
Journal:  Osteoarthritis Cartilage       Date:  2018-12-22       Impact factor: 6.576

5.  Atlas of individual radiographic features in osteoarthritis, revised.

Authors:  R D Altman; G E Gold
Journal:  Osteoarthritis Cartilage       Date:  2007       Impact factor: 6.576

6.  Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales.

Authors:  U T Kadam; K Jordan; P R Croft
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 7.  Mortality in osteoarthritis.

Authors:  M C Hochberg
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473

8.  Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work.

Authors:  J J Anderson; D T Felson
Journal:  Am J Epidemiol       Date:  1988-07       Impact factor: 4.897

9.  Pain and Mortality in Older Adults: The Influence of Pain Phenotype.

Authors:  Diane Smith; Ross Wilkie; Peter Croft; John McBeth
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02       Impact factor: 4.794

10.  Reasons why osteoarthritis predicts mortality: path analysis within a Cox proportional hazards model.

Authors:  Ross Wilkie; Simran Singh Parmar; Milica Blagojevic-Bucknall; Diane Smith; Martin J Thomas; Bethany Jane Seale; Gemma Mansell; George Peat
Journal:  RMD Open       Date:  2019-11-13
View more
  5 in total

1.  Lower Limb Muscle Strength and Muscle Mass Are Associated With Incident Symptomatic Knee Osteoarthritis: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Sinisa Stefanac; Ai Koyanagi; Nasser M Al-Daghri; Shaun Sabico; Cyrus Cooper; Renè Rizzoli; Jean-Yves Reginster; Mario Barbagallo; Ligia J Dominguez; Lee Smith; Stefania Maggi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-16       Impact factor: 5.555

2.  Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study.

Authors:  Shinichi Kawai; Satoshi Sobajima; Masashi Jinnouchi; Hideshi Nakano; Hideaki Ohtani; Mineo Sakata; Takeshi Adachi
Journal:  Clin Drug Investig       Date:  2022-04-18       Impact factor: 2.859

3.  Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial.

Authors:  Olivier Bruyère; Jean-Yves Reginster; Germain Honvo
Journal:  Rheumatol Ther       Date:  2022-06-03

4.  Experiences of activity monitoring and perceptions of digital support among working individuals with hip and knee osteoarthritis - a focus group study.

Authors:  Elin Östlind; Eva Ekvall Hansson; Frida Eek; Kjerstin Stigmar
Journal:  BMC Public Health       Date:  2022-08-30       Impact factor: 4.135

Review 5.  The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.

Authors:  Win Min Oo; Christopher Little; Vicky Duong; David J Hunter
Journal:  Drug Des Devel Ther       Date:  2021-07-06       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.